WHO ICTRP trial
A multicenter, randomized, double-blind, placebo parallel controlled clinical…
ITMCTR2023000020 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting
Key facts
| Trial ID | ITMCTR2023000020 |
|---|---|
| Public title | A multicenter, randomized, double-blind, placebo parallel controlled clinical trial on the efficacy and safety of Lianhua Qingwen granules in the treatment of acute pharyngitis |
| Scientific title | A multicenter, randomized, double-blind, placebo parallel controlled clinical trial on the efficacy and safety of Lianhua Qingwen granules in the treatment of acute pharyngitis |
| Primary sponsor | The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-marketing clinical trial |
| Countries | China |
| Conditions | Acute pharyngitis |
| Interventions | placebo group:Lianhua Qingwen Granule Simulator;test group:Lianhua Qingwen Granules |
| Registration date | Jul 6, 2023 |
| Target size | placebo group:246;test group:246 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: